Soo RA - Search Results

1

Resectable non-small cell lung cancer: an evolving landscape.

Loh J, Wijaya ST, Sooi K, Chia PL, Soo RA. Loh J, et al. Among authors: soo ra. Transl Lung Cancer Res. 2022 Jul;11(7):1241-1246. doi: 10.21037/tlcr-22-520. Transl Lung Cancer Res. 2022. PMID: 35958327 Free PMC article. No abstract available.

2

Immunotherapy in the treatment of non-small cell lung cancer.

Sundar R, Soong R, Cho BC, Brahmer JR, Soo RA. Sundar R, et al. Among authors: soo ra. Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14. Lung Cancer. 2014. PMID: 24880938 Free PMC article. Review.

3

Shedding light on the molecular determinants of response to anti-PD-1 therapy.

Soo RA. Soo RA. Transl Lung Cancer Res. 2015 Dec;4(6):816-9. doi: 10.3978/j.issn.2218-6751.2015.05.06. Transl Lung Cancer Res. 2015. PMID: 26798594 Free PMC article.

4

Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.

Soo RA, Kubo A, Ando M, Kawaguchi T, Ahn MJ, Ou SI. Soo RA, et al. Clin Lung Cancer. 2017 Sep;18(5):535-542. doi: 10.1016/j.cllc.2017.01.005. Epub 2017 Jan 19. Clin Lung Cancer. 2017. PMID: 28433570

5

The KEY to the end of chemotherapy in non-small cell lung cancer?

Huang Y, Soo RA. Huang Y, et al. Among authors: soo ra. Ann Transl Med. 2017 Apr;5(7):166. doi: 10.21037/atm.2017.03.55. Ann Transl Med. 2017. PMID: 28480202 Free PMC article. No abstract available.

6

The KEY to the end of the chemotherapy in advanced non-small cell lung cancer, or not yet?

Huang Y, Walsh RJ, Soo RA. Huang Y, et al. Among authors: soo ra. Transl Lung Cancer Res. 2019 Oct;8(5):731-737. doi: 10.21037/tlcr.2019.04.17. Transl Lung Cancer Res. 2019. PMID: 31737512 Free PMC article. No abstract available.

7

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre.

Chan GH, Gwee YX, Low JL, Huang Y, Chan ZY, Choo JR, Ngoi NY, LE Ang Y, Muthu V, Chong WQ, Wong A, Soo RA. Chan GH, et al. Among authors: soo ra. Lung Cancer. 2020 Aug;146:145-153. doi: 10.1016/j.lungcan.2020.05.020. Epub 2020 May 21. Lung Cancer. 2020. PMID: 32540557

8

A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians.

Peng S, Ying AF, Tai BC, Soo RA. Peng S, et al. Among authors: soo ra. Transl Lung Cancer Res. 2020 Aug;9(4):1124-1137. doi: 10.21037/tlcr-20-246. Transl Lung Cancer Res. 2020. PMID: 32953491 Free PMC article.

9

Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study.

Zeng Z, Yan B, Chen Y, Zhang L, Zhu J, Yang F, Wei F, Tam TCC, Kauffmann-Guerrero D, Soo RA, Ren X, You J. Zeng Z, et al. Among authors: soo ra. Transl Lung Cancer Res. 2020 Dec;9(6):2401-2410. doi: 10.21037/tlcr-20-1214. Transl Lung Cancer Res. 2020. PMID: 33489802 Free PMC article.

10

How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC).

Xia B, Nagasaka M, Zhu VW, Ou SI, Soo RA. Xia B, et al. Among authors: soo ra. Transl Lung Cancer Res. 2020 Dec;9(6):2521-2534. doi: 10.21037/tlcr-20-331. Transl Lung Cancer Res. 2020. PMID: 33489815 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page